Literature DB >> 21342283

Coagulopathy in α-galactosyl transferase knockout pulmonary xenotransplants.

Errol L Bush1, Andrew S Barbas, Zoie E Holzknecht, Guerard W Byrne, Christopher G McGregor, William Parker, R Duane Davis, Shu S Lin.   

Abstract

BACKGROUND: After substantial progress on many fronts, one of the remaining barriers still opposing the clinical application of xenotransplantation is a disseminated intravascular coagulopathy (DIC) that is observed in the pre-clinical model of porcine-to-primate transplantation. The onset of DIC is particularly rapid in recipients of pulmonary xenografts, usually occurring within the first days or even hours of reperfusion.
METHODS: In this study, we describe the results of two porcine-to-baboon transplants utilizing porcine lungs depleted of macrophages, deficient in the α-1,3-galactosyltransferase gene, and with the expression of human decay-accelerating factor, a complement regulatory protein.
RESULTS: In both cases, evidence of DIC was observed within 48 h of reperfusion, with thrombocytopenia and increases in levels of thrombin-antithrombin complex evident in both cases. Depletion of fibrinogen was observed in one graft, whereas elevation of D-dimer levels was observed in the other. One graft, which showed focal lymphocytic infiltrates pre-operatively, failed within 3 h.
CONCLUSIONS: The results indicate that further efforts to address the coagulopathy associated with pulmonary xenotransplantation are needed. Further, evidence suggests that resident porcine immune cells can play an important role in the coagulopathy associated with xenotransplantation.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21342283     DOI: 10.1111/j.1399-3089.2011.00621.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  8 in total

1.  Expression of human CD46 modulates inflammation associated with GalTKO lung xenograft injury.

Authors:  L Burdorf; T Stoddard; T Zhang; E Rybak; A Riner; C Avon; A Laaris; X Cheng; E Sievert; G Braileanu; A Newton; C J Phelps; D Ayares; A M Azimzadeh; R N Pierson
Journal:  Am J Transplant       Date:  2014-04-02       Impact factor: 8.086

Review 2.  Clinical lung xenotransplantation--what donor genetic modifications may be necessary?

Authors:  David K C Cooper; Burcin Ekser; Christopher Burlak; Mohamed Ezzelarab; Hidetaka Hara; Leela Paris; A Joseph Tector; Carol Phelps; Agnes M Azimzadeh; David Ayares; Simon C Robson; Richard N Pierson
Journal:  Xenotransplantation       Date:  2012 May-Jun       Impact factor: 3.907

Review 3.  Lung xenotransplantation.

Authors:  Hisashi Sahara; Hironosuke Watanabe; Thomas Pomposelli; Kazuhiko Yamada
Journal:  Curr Opin Organ Transplant       Date:  2017-12       Impact factor: 2.640

Review 4.  Lung xenotransplantation: recent progress and current status.

Authors:  Donald G Harris; Kevin J Quinn; Siamak Dahi; Lars Burdorf; Agnes M Azimzadeh; Richard N Pierson
Journal:  Xenotransplantation       Date:  2014-07-05       Impact factor: 3.907

Review 5.  Future prospects for tissue engineered lung transplantation: decellularization and recellularization-based whole lung regeneration.

Authors:  Tomoshi Tsuchiya; Amogh Sivarapatna; Kevin Rocco; Atsushi Nanashima; Takeshi Nagayasu; Laura E Niklason
Journal:  Organogenesis       Date:  2014-01-31       Impact factor: 2.500

6.  Rhesus monkeys and baboons develop clotting factor VIII inhibitors in response to porcine endothelial cells or islets.

Authors:  John M Stewart; Alice F Tarantal; Wayne J Hawthorne; Evelyn J Salvaris; Philip J O'Connell; Mark B Nottle; Anthony J F d'Apice; Peter J Cowan; Mary Kearns-Jonker
Journal:  Xenotransplantation       Date:  2014-05-08       Impact factor: 3.907

7.  Four-dimensional characterization of thrombosis in a live-cell, shear-flow assay: development and application to xenotransplantation.

Authors:  Donald G Harris; Prabhjot K Benipal; Xiangfei Cheng; Lars Burdorf; Agnes M Azimzadeh; Richard N Pierson
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

Review 8.  Genetically Modified Pigs as Organ Donors for Xenotransplantation.

Authors:  Magdalena Hryhorowicz; Joanna Zeyland; Ryszard Słomski; Daniel Lipiński
Journal:  Mol Biotechnol       Date:  2017-10       Impact factor: 2.695

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.